Dr. Nazmi Baycin, DHA-licensed board-certified plastic surgeon in Dubai
A patient is not a candidate for J-Plasma when the problem is skin excess rather than skin laxity, because helium-plasma energy contracts the envelope you already have and cannot remove measurable skin, redistribute volume or repair muscle. Technologies like J-Plasma are powerful tools that I use within my surgical practice, but their appropriate use is defined as much by their limitations as by their capabilities. A large part of my consultations in Dubai involves recalibrating expectations for patients who have been led to believe that an energy-based device can replace foundational surgical principles. It is an exceptional adjunct for precise soft-tissue contraction; it is not a substitute for excisional surgery when the anatomy demands it. My duty is to identify clearly who will not benefit, so that you invest in the solution that matches your anatomy rather than a marketed promise.

This article covers the limits of J-Plasma: what the evidence and the regulator say, who is not a candidate and why, the medical and skin factors that rule it out or postpone it, what happens when it is used on the wrong patient, and why trying it first can be a setback. How I predict before liposuction who will need it, and why it is done in the same session, is in my article on J-Plasma after liposuction; how it differs from external heat-based tightening in J-Plasma versus traditional skin tightening; the collagen science and the safety limits I work within in how J-Plasma contracts tissue; and candidacy, technique, recovery, risks and cost on J-Plasma (Renuvion) in Dubai.

What are the key takeaways about the limits of J-Plasma for patients in Dubai?

J-Plasma tightens the skin you have and removes none of it, so the people it cannot help are those with true skin excess, with a stretched post-weight-loss envelope, with fat still to be removed, or who want surgery’s result without surgery.

  • J-Plasma contracts the existing skin envelope; it does not remove measurable skin.
  • The primary contraindication is true skin excess, identified with a simple pinch test.
  • Massive weight loss patients need excisional surgery, not energy-based tightening.
  • High BMI or thick residual fat dampens the effect; the volume must be addressed first.
  • It is a surgical adjunct, performed under anesthesia, not a non-surgical treatment.
  • The published evidence does not show tightening beyond liposuction alone, and the device has caused serious burns and gas injuries when misused.
  • The ideal candidate needs refinement, not reduction: mild laxity with good elasticity.

What do the evidence and the regulator say about J-Plasma?

The evidence says that no published study has shown J-Plasma tightening skin beyond what liposuction alone achieves, and the regulator says it may be used beneath the skin after liposuction, and for the neck, but warned against its use as a skin-tightening treatment on its own. Honest expectations here are backed by that record. A 2025 systematic review of helium-plasma radiofrequency, the first review of the device, found that the twenty-five publications with usable patient data relied on surgeons’ subjective assessment of photographs, that none measured the result against liposuction alone on standardized photographs, and that most were funded by the manufacturer. On that basis it found no evidence of skin tightening beyond what traditional or ultrasonic liposuction achieves.

The same review is blunt about safety. Across 135 adverse-event reports filed with the FDA between 2020 and 2025 it counted fifteen events classed as life-threatening and three deaths, most involving burns or helium tracking into a body cavity. Two things should be weighed with it: those reports are voluntary and carry no denominator, so they cannot establish a rate, and the review is the work of a single author who is a long-standing critic of energy-based devices. It is still the reason I use this device only under anesthesia, in an accredited hospital, in the subcutaneous plane after liposuction, and never as a stand-alone skin treatment.

The regulatory record of J-Plasma (Renuvion) for aesthetic use, in order
Date What happened What it means for you
March 2022 The FDA warned against using the device for dermal resurfacing or skin contraction; at that time it was cleared only for cutting, coagulation and ablation in open and laparoscopic surgery Stand-alone “skin tightening” with the device was never a cleared use, and the warning still applies to it
May 2022 A dermal handpiece was cleared for moderate to severe wrinkles in lighter skin types A surface use, not the subcutaneous use discussed on this page
July 2022 The subcutaneous handpiece was cleared for use under the skin to improve the appearance of lax skin in the neck and under the chin The first cleared use beneath the skin, limited to the neck
April 2023 The same handpiece was cleared for coagulation of subcutaneous soft tissue following liposuction for aesthetic body contouring This is the way I use the device on the body: beneath the skin, after liposuction, in the same operation

How to read this table: the first row is often quoted without the third, and the third without the first; both are true. The device is cleared for use under the skin after liposuction, and for the neck, and was warned against as a skin-tightening treatment in its own right, which is exactly the distinction this article is about. The dates are taken from the FDA’s own safety communication.

The dates above are those given in the FDA’s May 2023 safety communication on the Renuvion and J-Plasma device, which also sets out its recommendations to patients and providers. That is not a reason to dismiss the technology. It is a reason to use it precisely, for the narrow set of patients it genuinely helps.

Why can J-Plasma tighten skin but not remove it?

J-Plasma can tighten skin but not remove it because its energy heats and contracts the collagen in the tissue beneath the skin, shrinking the envelope by a fraction, whereas excess skin is a surplus of envelope that only excision can shorten. The principle that guides my candidacy assessment is that simple. The device contracts the soft-tissue envelope you already have, a focused-energy mechanism I contrast with older heat-based devices in my article on J-Plasma versus traditional skin tightening. It does not remove measurable amounts of skin, redistribute volume, or repair muscular diastasis.

So the primary contraindication, in my plastic surgery practice in Dubai, is true skin excess. I identify this with a pinch test. If I can grasp a substantial fold of skin that does not retract when released, the problem is excess, not laxity, and no amount of energy-induced contraction will meaningfully shorten that envelope. For those patients a formal excisional procedure, such as an abdominoplasty or a body lift, is the correct, definitive solution. The distinction is not academic: choosing tightening when the true problem is excess wastes both money and recovery time, and it delays the operation that would actually have worked.

Infographic on who is and is not a candidate for J-Plasma, explaining that it tightens the existing skin envelope but does not remove skin. It shows the pinch test as the decider: skin that recoils quickly is laxity and a good sign, while a fold that stays is excess that J-Plasma cannot fix. On the left, often NOT a candidate: true skin excess needing excision, massive weight loss with a stretched sack-like envelope, high BMI or thick fat that dampens the effect, and poor skin quality or those wanting no surgery. On the right, the ideal candidate: mild to moderate laxity after successful liposuction, good skin elasticity with rapid recoil, stable weight and realistic goals, and final contour refinement rather than reduction

Who is and is not a candidate for J-Plasma: the pinch test, the profiles it cannot help, and the ones it can, by Dr. Nazmi Baycin, Dubai.

Who in Dubai is not a candidate for J-Plasma?

Five profiles are not candidates for J-Plasma: patients with true skin excess, patients after massive weight loss, patients with a high BMI or thick residual fat, patients with poor skin quality, and patients who want the result of surgery without having surgery. Over many consultations in Dubai I have come to recognize these patterns clearly, and the table sets each against the reason and the better path.

The profiles for whom J-Plasma alone is the wrong choice, why, and the better path
Often not a candidate Why Better path
True skin excess The envelope must be shortened, not tightened; a fold that stays when pinched cannot be contracted away Abdominoplasty, arm lift, thigh lift or body lift
Massive weight loss The skin is stretched beyond its elastic capacity and hangs like an empty, redundant sack Excisional body contouring, staged as needed
High BMI or thick residual fat The fat layer mechanically dampens the contraction, and the visible effect is negligible Address the fat first, usually with liposuction; reassess the skin afterwards
Poor skin quality Severely sun-damaged, chronically thin or extensively stretch-marked skin has a diminished collagen response Reassess suitability frankly; sometimes a smaller gain is still worthwhile, often it is not
Wants a dramatic change without surgery J-Plasma is itself surgery: anesthesia, cannula incisions and a recovery period A candid conversation first; the expectation, not the anatomy, is the mismatch

How to read this table: the first two rows are anatomical limits that no device changes; the third is a limit that liposuction can remove; the fourth is a limit of the tissue itself; and the fifth is a limit of expectation. Why the skin fails to retract after liposuction in the first place, and how that is predicted before surgery, is in my article on J-Plasma after liposuction.

After significant weight loss, no energy-induced contraction can shorten the surplus meaningfully, so these patients need formal excisional surgery, a topic I cover in my article on post-bariatric body contouring for the massive weight loss patient. Perhaps the most common mismatch of all is the patient who wants a dramatic change but wishes to avoid surgery entirely. J-Plasma is a surgical adjunct, performed under anesthesia, requiring incisions for cannula access, and involving a recovery period. It is not a non-surgical treatment.

Which medical and skin factors rule out or postpone J-Plasma?

Beyond the five anatomical profiles, several medical and skin factors rule out J-Plasma or postpone it, because the device delivers real heat into the tissue beneath the skin and the skin above must be able to survive and heal over it. These are assessed at the same consultation as the pinch test, and a “yes” to one of them is more often a reason to wait or to change the plan than a permanent refusal.

Medical and skin factors that rule out or postpone J-Plasma, and what each changes
Factor Why it matters with a heat-based device What it changes
Current smoking Narrows the vessels that must carry the heated skin through healing; raises the risk of a burn becoming a wound You are advised not to smoke during the recovery period, while the heated layer and the entry points heal
Active infection or an open wound in the area Heat and a cannula through infected tissue spread it Postponed until fully healed
Very thin skin over the area, or previous burns or radiotherapy there Less tissue between the energy and the surface, so a burn is more likely Usually ruled out for that area
A history of keloid or hypertrophic scarring The entry points and the heated layer can scar more than expected Discussed frankly; the small entry points are placed where a scar matters least
Pregnancy or breastfeeding No elective surgery, and the skin will change again afterwards Postponed until well after
Uncontrolled diabetes or a condition that impairs healing A heated layer heals more slowly and is less forgiving of poor healing Postponed until controlled, with the prescribing physician involved
An unstable weight Contraction achieved now is undone by the next gain or loss Postponed until the weight has been stable for months

How to read this table: most rows say “postponed”, not “never”; the third row is the one that most often rules an area out altogether. The general suitability and safety checklist for the operation is on my procedure page.

What happens when J-Plasma is used on the wrong patient?

When J-Plasma is used on the wrong patient, the best case is a result too small to notice and the worst is a new problem: contour irregularity, a burn, or fibrosis under skin that still hangs. On true excess the contraction shortens the envelope by a few percent where the problem is a surplus of a third or more, so the fold remains and the money and recovery are spent. On a thick fat layer the heat is absorbed before it reaches the skin, so nothing visible changes. On thin or damaged skin the margin between contraction and burn is narrow, which is where the full-thickness burns in the adverse-event reports come from.

There is a quieter harm as well. The heated layer heals with fibrosis, and in the wrong patient that fibrosis sits beneath skin that will later need to be lifted or removed. It does not dissect as cleanly, and it can alter the blood supply to the skin the later operation depends on. That is the subject of the next section, and it is why the initial diagnosis matters more than the choice of device.

Why is trying J-Plasma first often a setback?

Trying J-Plasma first is often a setback because it costs the money and recovery of a procedure unlikely to work, and because the fibrosis it leaves can make the definitive operation harder and riskier. I sometimes meet patients who have been advised to try J-Plasma first and consider surgery later if it is not enough. In my view this is often a disservice. Scarred, fibrotic tissue does not dissect as cleanly, and a compromised blood supply raises the risk profile of the excision that eventually follows.

My philosophy is to perform the correct, definitive procedure first, based on an uncompromised anatomical assessment. This is a question of judgment over marketing, the same principle I discuss in my article on why surgeon technique matters more than technology.

Who does J-Plasma help, by contrast?

J-Plasma helps the patient who needs refinement rather than reduction: mild to moderate skin laxity after successful liposuction, good elasticity with rapid recoil on the pinch test, a stable weight, and realistic expectations. For this group the device is a superb tool for final contour refinement, used in the same operation as the liposuction. How I predict at consultation which liposuction patients will need it, why it must be done in the same session, and how it prevents over-treatment are the subject of my article on J-Plasma after liposuction and when it prevents secondary skin laxity, and whether you are a candidate at all is answered on my procedure page. Because candidacy is so individual, both suitability and cost are best assessed at a consultation; the investment is only worthwhile when the tool actually matches the problem.

J-Plasma is a refined instrument in my toolkit, but it is not a wand. Its appropriate application is a matter of surgical judgment, not technological marketing. The most valuable service I offer is often the candid, sometimes firm, counsel that steers a patient away from a procedure that cannot help them and toward the one that will.

Where can you read about each part of J-Plasma in more depth?

This article covers the limits of J-Plasma and who it cannot help; the pages below cover each other part in depth.

What do patients in Dubai ask about the limits of J-Plasma?

Patients ask me why J-Plasma does not work after massive weight loss, whether it is non-surgical, whether they should try it before surgery, whether it can be repeated, what the FDA warning means, and what to do if they were promised it would fix loose skin; the answers are below.

  1. Why is J-Plasma not suitable after massive weight loss?

    After significant weight loss, the skin envelope is often stretched far beyond its elastic capacity and resembles an empty, redundant sack. No amount of energy-induced contraction can meaningfully shorten that much excess tissue. These patients need formal excisional body contouring, procedures that physically remove the surplus skin and reshape the contour, such as a tummy tuck, a body lift or an arm lift. Using J-Plasma in this situation would produce minimal, disappointing improvement and leave fibrosis under skin that still has to be removed. Recognizing when excision is required, rather than tightening, is one of the most important judgments in body contouring.

  2. Is J-Plasma a non-surgical treatment?

    No, and this is a common misunderstanding. J-Plasma is a surgical adjunct. It is performed under anesthesia, requires small incisions for cannula access, and involves a genuine recovery period. Patients who want a dramatic transformation while avoiding surgery altogether are not good candidates, because the treatment simply does not fit that expectation. Managing this early in the conversation is an important part of a candid consultation. If avoiding surgery entirely is your priority, it is better to know from the outset that this is not the non-surgical shortcut it is sometimes marketed to be.

  3. Should I try J-Plasma first and consider surgery later?

    I generally advise against this sequential approach. Trying an under-powered treatment first means paying for, and recovering from, a procedure unlikely to solve the problem. More importantly, the internal fibrosis it creates can complicate a later operation, making tissue dissection harder and potentially affecting the blood supply. My philosophy is to perform the correct, definitive procedure first, based on a clear anatomical assessment, rather than stacking an ineffective step in front of it. Doing the right operation once protects both your result and your investment.

  4. Can J-Plasma be repeated if the first result was not enough?

    Rarely, because an under-dosed first treatment is seldom the reason a result falls short. In my technique the energy is applied in three passes in the same operation, through the deep, the middle and the superficial layers of the subcutaneous tissue, so the full contraction the skin can give is taken at the first sitting. If the result still fell short, the question is why. If the skin was excess rather than lax, a second session contracts a surplus that still cannot be shortened, and the answer is excision, not more heat. If fat was left in the way, the fat is the problem to treat. I would rather diagnose the first treatment correctly than rely on a second.

  5. Why did the FDA warn against J-Plasma for skin tightening, and is it still a concern?

    In March 2022 the FDA warned against using the device for skin contraction because at that time it held no clearance for any aesthetic use and serious injuries had been reported, including burns and helium escaping into body cavities. Since July 2022 the subcutaneous handpiece has been cleared for lax skin of the neck and under the chin, and since April 2023 for coagulation of subcutaneous soft tissue following liposuction for body contouring, which is the only way I use it. The warning remains relevant to the use it was aimed at: the device offered as a stand-alone skin-tightening treatment, outside the subcutaneous plane, outside an operating room. Used within its clearance, under anesthesia, after liposuction, in an accredited hospital, the risks are the ones I set out and control.

  6. What should I do if I was told J-Plasma would fix my loose skin?

    Ask for the pinch test before you decide anything. Pinch the loose skin, let it go and watch: if it snaps back, you have laxity, and tightening may help as part of a liposuction plan; if a fold stays in your fingers, you have excess, and the honest answer is an operation that removes skin. Ask the clinic whether the device will be used under anesthesia in the subcutaneous plane after liposuction, which is its cleared use, or offered on its own, which is the use the regulator warned against. And ask what they expect to happen if the result falls short, because a plan that ends with excision was a plan that should have started with it.



Book a private consultation with Dr. Baycin in Dubai

Get ready to look and feel best… You deserve…

Contact Dr. Nazmi Baycin's Dubai clinic for a private consultation
Click For Instant Contact or Send Message

    Go To Top
    About Dr. Nazmi Baycin

    Surgery, to me, is precision applied in service of restoration — a conviction that has guided every one of the more than 7,000 procedures I have performed over 25 years in practice. I am a DHA-licensed, board-certified plastic surgeon, trained in Turkey and based in Dubai since 2016. I operate exclusively within JCI-accredited hospitals, and hold international membership in the American Society of Plastic Surgeons (ASPS). Three techniques, in particular, have become signatures of my practice. Scarless breast augmentation, performed through a transaxillary approach that leaves no incision on the breast itself. Labiaplasty designed individually around each patient's own anatomy, never to a standard template. And 3D customised facial bone implants, engineered through CT-based bespoke printing — a technique I currently offer as the only surgeon in Dubai providing it. My practice today spans facial rejuvenation, breast surgery, body contouring, and cosmetic genital procedures, drawing patients from across the UAE, Europe, and the wider GCC. Yet the principle guiding each of these specialties has never changed: to restore form is to restore function. Last reviewed: November 2026. Read Dr. Baycin's full profile

    error: Content is protected !!